NASDAQ:IMGN

ImmunoGen, Inc Earning Date

USA |NASDAQ |USD

IMGN Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Oct 29, 2021 Sep 2021 $-0.18 $-0.15 $-0.13
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Oct 29, 2021 Sep 2021 $19.03M $16.95M $18.19M

Immunogen, Inc's next earnings date is Friday, Oct 29, 2021 for the fiscal quarter ending Sep 2021.

IMGN Earnings Date & History Chart

IMGN Earnings & Revenue Forecast

IMGN Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 9 $-0.22 $-0.25 $-0.18
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 9 $-0.72 $-0.75 $-0.69
Dec 2022 9 $-0.85 $-1.44 $-0.62

IMGN Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.22 $-0.22 $-0.23
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.72 $-0.73 $-0.78
Dec 2022 0 / 1 $-0.78 $-0.82 $-0.81

IMGN Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 9 $18.89M $14.20M $23.50M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 9 $70.61M $66.54M $74.71M
Dec 2022 9 $70.62M $33.00M $121.00M

IMGN Earnings Date & Revenue History

IMGN Earnings History

|
Show More
Show More

IMGN Revenue History

|
Show More
Show More

Immunogen, Inc Next Earnings Date & Report

IMGN Next Earnings Date & Report Preview: Sep 2021 (FQ)

IMGN's next earnings date is Friday, Oct 29, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 9 analysts, the average EPS estimation for Immunogen, Inc's next quarterly earnings is $-0.18, with a low EPS estimation of $-0.20, and a high estimation of $-0.17.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.18, the last 2 month trend is $-0.18, and the 3 month trend is $-0.20.

Based on 9 analysts, the average revenue estimation is $19.03M, with a low revenue estimation of $15.24M, and a high estimation of $22.30M.

Immunogen, Inc Previous Earnings Dates & Reports

IMGN Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Immunogen, Inc's previous earnings date was Jul 30, 2021 for its fiscal quarter ended Jun 30, 2021.

IMGN's earnings per share (EPS) was $-0.15, beating the consensus analysts forecast of $-0.18 by 17.85%.

The EPS was higher than the previous fiscal quarter (Mar 2021) by -11.76%, and lower than the same period a year before (Jun 2020) by 7.14%.

Revenues were $16.95M, better than the forecast of $16.95M by 0.00%, up by 7.91% from the previous quarter , and up by 12.80% from the same period last year.

The company reported a net income of $-30.74M.

Free cash flow for the quarter was $-43.93M , compared to $-45.51M last quarter and $-28.22M a year before.

IMGN ended the quarter with $21.27M in total debt, a decrease of -7.89% compared to the previous quarter, and a decrease of -16.32% compared to the same quarter a year before.

IMGN Previous Earnings Date & Report Recap: Dec 2020 (FY)

Immunogen, Inc's previous annual earnings date was Feb 12, 2021 for its fiscal year ended Dec 31, 2020.

IMGN's earnings per share (EPS) was $-0.28, beating the consensus analysts forecast of $-0.52 by -46.15% , and higher than the previous year's EPS (Dec 2019) by -60.56%.

Revenues were $132.30M, better than the forecast of $87.28M by 51.58%, and up by 60.81% from previous year's revenue.

The company reported a net income of $-44.37M.

Immunogen, Inc reported a free cash flow of $-79.54M for its fiscal year, compared to $-91.21M a year ago.

The company ended the fiscal year with $23.89M in total debt, an increase of 373.16% compared to the previous year.